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Abstract
Background: Whole genome and exome sequencing are contributing to the extraordinary progress in the study of
human genetic variants. In this fast developing field, appropriate and easily accessible tools are required to facilitate
data analysis.
Results: Here we describe QueryOR, a web platform suitable for searching among known candidate genes as well
as for finding novel gene-disease associations. QueryOR combines several innovative features that make it comprehensive,
flexible and easy to use. Instead of being designed on specific datasets, it works on a general XML schema specifying
formats and criteria of each data source. Thanks to this flexibility, new criteria can be easily added for future
expansion. Currently, up to 70 user-selectable criteria are available, including a wide range of gene and variant features.
Moreover, rather than progressively discarding variants taking one criterion at a time, the prioritization is achieved by a
global positive selection process that considers all transcript isoforms, thus producing reliable results. QueryOR is easy
to use and its intuitive interface allows to handle different kinds of inheritance as well as features related to sharing
variants in different patients. QueryOR is suitable for investigating single patients, families or cohorts.
Conclusions: QueryOR is a comprehensive and flexible web platform eligible for an easy user-driven variant
prioritization. It is freely available for academic institutions at http://queryor.cribi.unipd.it/.
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Background
Over the past few years, the advances in DNA sequen-
cing technology have opened new perspectives in many
fields of Life Sciences. In particular, Whole Genome Se-
quencing (WGS) and Whole Exome Sequencing (WES)
are contributing to the extraordinary progress in the
study of genetic variants, improving the understanding
of causative genes in human disorders.
While “Next Generation Sequencing” (NGS) is making
the production of sequencing data progressively easier,
bioinformatic analysis is still a problem when dealing
with genes and pathologies not well characterized at the
molecular level.
The initial bioinformatic steps for variant analysis are
quite standard: the NGS reads are firstly aligned on the
human reference genome [1], then the resulting SAM
file [2] is parsed for the identification of genomic vari-
ants. As a result, a Variant Call Format (VCF) file with
the list of variants is generated [3].
The selection of candidate variants responsible for the
phenotype or disease under study remains a challenging
task. Firstly, we need to functionally characterize and an-
notate the large number of variants that are typically de-
tected: tens of thousands for WES and millions for WGS.
Several approaches have been developed to accomplish
this task. Programs like SIFT [4] and PolyPhen-2 [5]
evaluate variants by focusing on the impact of amino acid
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changes on protein function, while ANNOVAR [6] ex-
tends the functional annotation considering other features
such as phylogenetically conserved regions and allele
frequency in populations.
Once the variants have been annotated further action is
required to choose the most effective criteria for “prioritiz-
ing” candidate causative variants. It is unfeasible to con-
ceive an all-purpose protocol as the type of problems and
the available data may be very disparate. Moreover, field-
specific expertise may be essential both in the definition of
the criteria and in the interpretation of the data.
If the genetic disease is well characterized at the mo-
lecular level, then the obvious action to take is to focus
on the variants occurring on known causative genes. Un-
fortunately, our knowledge is still limited as ~50% of
Mendelian monogenic diseases have not yet been associ-
ated with causative genes [7], while most polygenic
disorders remain uncharacterized at the molecular level.
Taking into consideration that the function of many
genes is still unknown, bioinformatic approaches such as
Endeavour [8] prioritize candidate genes on features
shared with other genes that are involved in the same
biological process or disease under study. Several
phenotype-driven approaches have been implemented in
programs like eXtasy [9], PhenIX [10], Phenolyzer [11],
PHIVE [12], Exomiser [13] and Phevor [14], taking ad-
vantage of resources such as Gene Ontology (GO) [15],
Human Phenotype Ontology (HPO) [16] and Disease
Ontology (DO) [17].
As previously mentioned, the prioritization process
usually requires the integration of a wide range of func-
tional information about variants, genes and diseases as
well as mode of inheritance when multiple individuals
are considered. Currently, the standard strategy involves
the application of filters with arbitrary thresholds that
progressively remove variants not satisfying the criteria.
As a result there is the risk of removing something that
is just below the threshold for one of the criteria, while
being well above the threshold for the other criteria.
Prioritization is not only confined to the problem of
merging information on variants, genes and phenotypes.
An issue that is often disregarded is that the vast major-
ity of genes undergo alternative splicing [18]. As a result
the same variant may have very different functional out-
comes, for instance it may generate a stop codon in a
transcript and a silent variant in another isoform of the
same gene. For this reason the annotation of variants
should refer to each alternative transcript rather than
the putative major isoform.
Recently, some web-servers [19] have been developed
to analyze exome data, but they do not satisfy most of
the above requirements, thus limiting the spectrum of
possible analyses. Stand-alone programs such as Variant-
Master are available [20], but they are driven by line-
commands that make their usage cumbersome and diffi-
cult for most users. An additional problem is that our
knowledge on human genomics is changing very rapidly
at all levels, needing continuous updates, implementa-
tions and integration of data, tools and ideas. Therefore,
a platform for prioritization that combines usability and
comprehensiveness has become a priority.
With these premises in mind, QueryOR has been engi-
neered as a user friendly web-platform that integrates
the most advanced prioritization criteria. Furthermore,
QueryOR is built on a robust set of XML-defined rules
that allows an easy implementation of new criteria with-
out modifying the program code. Currently, 70 different
criteria of prioritization have been implemented in the
platform and can be selected by users to build dynamic
tailor-made queries and to facilitate expert-driven variant
and gene prioritization.
Implementation
Web-interface implementation
QueryOR has been implemented in CGI/Perl combined
with Apache web-server. JavaScript, Jquery, AJAX and
CSS properties are used to dynamically render some
parts of HTML pages and to define their structures and
layouts. The pages for criteria selection and transcript
report are built on dedicated XML-files. For this reason,
we have developed a XML-language that describes
standard database queries and their web representation
(layout, form elements, hyperlinks, highlighted columns).
Thus, any selection criterion or transcript data table is
completely specified in a XML node, making the system
flexible and scalable. The XML language also allows the
user to integrate custom databases into the QueryOR
platform. This integration is easily obtained loading mul-
ticolumn files with information related to genes (one
column must contain the ENSEMBL gene ID) or vari-
ants (four columns are mandatory: chromosome, pos-
ition, reference allele and alternative allele). Once the
file is loaded, the user can select the fields on which one
or more filters have to be created. Then, the system
automatically fills a new database associated to the pro-
ject and builds specific XML-files containing the new
queries, which will be available with all other criteria.
Data processing implementation
The data processing step is based on in-house scripts de-
veloped in Perl, Python and Bash; it runs on a blade
cluster, managed by a PBS job resource manager
(TORQUE). ANNOVAR software and dbNSFP database
(v2.9) [21] are used for the annotation of variants, in
addition to a homemade script. All project data are
stored in a local database using MariaDB, a MySQL
open-source fork, with the TokuDB® engine. The data-
base is designed to contain both annotation tables and
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user data tables. The former host human gene annota-
tions and known SNP information (global minor allele
frequency, clinical significance, etc.) and are regularly
updated every 6 months. The latter stores the data
uploaded by the user and the associated meta-data pro-
duced during the “Data processing” step.
ENSEMBL data and variant annotation integration
The hg19 release 81 of human gene and transcript data
has been downloaded from ENSEMBL (http://grch37.en-
sembl.org/info/data/ftp/) [22]. Two different databases
of known mutations have been integrated in the plat-
form: dbSNP [23] version 144 (http://www.ncbi.nlm.-
nih.gov/SNP/) [24], modified to recover old variants
excluded from this last release but present in the online
version, and Exome Variant Server version ESP6500SI-
V2 (http://evs.gs.washington.edu/EVS/) [25] have been
chosen to annotate allelic frequencies in the population.
Disease information has been obtained from OMIM
(http://www.omim.org/) [26] and associated to gene and
transcript data. Regarding somatic mutations, QueryOR
incorporates COSMIC database [27] version 74, whose
SQL table has been created starting from VCF files con-
taining both coding and non-coding mutations and the
complete export file of COSMIC. In case of new releases
of gene annotations, dbSNP files or OMIM data, a cus-
tom set of Perl/Python scripts have been developed for
the automatic update of all SQL tables.
Integration of functional and phenotypic annotations
QueryOR integrates several gene annotations derived
from different public databases, which have been directly
obtained from their respective websites or through
ENSEMBL BioMart [28]. Within these annotations,
QueryOR embeds Gene Ontology [29] and InterPro [30]
data, as well as two different pathway repositories,
KEGG (Kyoto Encyclopedia of Genes and Genomes)
[31] and Reactome [32], which have been collected using
the Graphite package [33] of Bioconductor [34]. Quer-
yOR also makes available gene expression data derived
from the GTEx portal (version 6) [35]. The information
contained in this atlas has been processed to link
Ensembl ID to tissues and sub-tissues in which the gene
is expressed. The level of expression is measured in
RPKM (Reads Per Kilobase per Million mapped reads)
[36]. Moreover, regarding the phenotype annotation, the
platform accommodates two main databases: DisGeNET
version 3.0 [37] and Human Phenotype Ontology
(HPO) release 98, whose entries have been further
processed to be associated to ENSEMBL-ID. The up-
dating of these functional annotations has been au-
tomatized through a set of Perl/Python scripts as
described in the previous section.
Chromosome map tool implementation
The “runs of homozygosity” (ROHs) are calculated by
comparing the user-uploaded variants and the high-
polymorphic dbSNP variants (GMAF higher than 0.3)
falling into the target regions. The algorithm extracts
those positions where only dbSNP variants, and no cus-
tom variants, are mapped. The resulting locations are
those with a homozygous genotype for the reference
allele (0/0) in the analyzed sample.
Using these spots, the script finds all the ROHs, com-
putes the length distribution and selects the stretches
whose length exceeds the 95th percentile of the distribu-
tion. Then, the algorithm tries to extend all the ROH
seeds in both directions as long as the homozygosity
ratio (number of positions with 0/0 genotype divided by
the sum of homozygous and heterozygous positions in
the considered region) remains above 0.9. ROHs are
used to build the “chromosome map” chart in associ-
ation with the genes selected during the prioritization
process.
Case study dataset
The exome data from the “Diagnostic Exome Sequen-
cing in Persons with Severe Intellectual Disability” (study
EGAS00001000287, https://www.ebi.ac.uk/ega/studies/
EGAS00001000287) [38, 39] were obtained from the
European Genome-Phenome Archive (EGA) web site.
Results
We have implemented QueryOR dividing the process
into three main steps as shown in Fig. 1.
Each step is further divided into different sub-steps
and procedures, as detailed below. Users will spend most
of their time at step 3, querying and browsing the system
in the search of possible causative variants. To test the
potential and features of the querying step, several sets
of data have been made openly available on the platform,
including some trio data from de Ligt et al. [38], as well
as data produced by our own group.
Fig. 1 The three main steps of QueryOR analysis. Step 1 and step 3
require interaction with the user, whereas step 2, data processing, is
automatically performed by the system after uploading VCF files
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Uploading and updating VCF files
All QueryOR’s activities are centered on projects that
the users can create and possibly share with their collab-
orators. Projects can be related to single individuals,
trios or families, as well as population or cohorts. Start-
ing a project is very simple, but users must first register,
both for privacy reasons and for permitting the retrieval
of their data.
The creation of a project requires the uploading of
VCF files that must satisfy several requirements. Firstly,
each individual sample should be labeled with a unique
name that will be used as identifier in the subsequent
steps. Secondly, the information about genotype, allelic
depth and total read depth, which are usually found in
the GT, AD and DP fields, must be available. Although
VCF is a well established format, not all variant callers
implement the VCF fields in the same way; for instance
the Torrent Variant Caller does not fill the AD and DP
fields. Therefore, we have developed specific scripts that
calculate the allelic and total read depth from other pa-
rameters, such as Alternate allele Observations (AO)
and Reference allele Observation count (RO). As a re-
sult, the platform accepts VCF files produced by all the
commonly used variant callers.
In the upload/update step the user can also upload
BED files containing regions of interest. BED files should
have four columns for each row: chromosome number,
starting position, ending position and sample ID; the lat-
ter is used to associate the genomic coordinates to the
right individual. These custom-defined regions will be
shown in the graphical synopsis of variants and tran-
scripts (Fig. 2-Q3) as yellow boxes. We usually exploit
this feature to mark on each sample the regions with
low coverage.
Once the files are uploaded, QueryOR takes some
time, from minutes to hours, to process data, depend-
ing on the number of uploaded samples and variants.
The user can check the job status while the process-
ing is running. The beginning and the end of the
process are notified by automatic emails to the user’s
registered address.
Data processing
Data are processed by an automatic back-end procedure
that provides a comprehensive annotation of the vari-
ants, linking them to genes, transcripts, encoded pro-
teins and biological ontologies. QueryOR takes into
consideration that alternative splicing may generate
Fig. 2 A typical route for a QueryOR investigation starts with the selection of criteria (Q1); a ranked list of genes and variants is returned in Q2.
The selection of a gene, for instance FUCA2, leads to page Q3 where variants and affected transcripts in their genomic context are shown. The
black track at the top of Q3 shows the target regions of exome capturing. The blue tracks just below show that the analysis was done on two
samples named APN and APM, that share a heterozygous variant (white circles). The yellow boxes report the positions specified in the optionally
uploaded BED file, indicating for instance low coverage regions. The bottom part of Q3 shows two alternative transcripts where the same variant
in one case is located in an exon, generating a missense substitution (dark blue circle) while in the other case is located in an intron (gray circle).
By clicking on a transcript of Q3, the system returns Q4, where several transcript features are directly linked to external resources, as well as to the
variant overview page (Q5). For a full list of symbols used in Q3, see Fig. 3. A more detailed description of the entire process is given in
the main text
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multiple transcripts from the same gene. As a result, a
variant may have different effects depending on the tran-
script isoform. With this premise, we thought that the
common practice of limiting variant annotation to the
major transcript isoform is a coarse approximation.
Therefore, to manage this problem QueryOR annotates
variants on all the predicted ENSEMBL transcripts
derived from alternative splicing events. Furthermore,
the distribution of variants on the different splicing
isoforms can be displayed and examined by the user
as a part of the interactive result analysis described in
the next paragraph.
Besides QueryOR’s own procedures, a further double
annotation is performed using both ANNOVAR [6] and
dbNSFP [21], thus obtaining a wide set of measures,
scores and constraints related to each variant, that
among others include SIFT [4], PolyPhen [5], Mutatio-
nAssessor [40] and GERP++ [41].
Data processing involves many other steps, including
the association of variants to the available information
in dbSNP, such as the allelic frequency in the global
population and in ethnic groups, as well as the presence
in the 1000 Human Genome Project [42]. Moreover, we
discovered several thousand SNPs in the reference gen-
ome (both in GRCh37 and GRCh38) that do not corres-
pond to the major allele in the population and as a
consequence are found as “false positive” in most indi-
viduals. To overcome this problem, the reference posi-
tions characterized by a dbSNP frequency lower than 0.1
are annotated as mAiRs (minor Allele in Reference).
When a project involves the analysis of multiple pa-
tients such as trios and families, the platform runs a spe-
cific module that automatically computes how variants
are shared between individuals. Moreover, possible Runs
of Homozygosity are calculated for each sample, as ex-
plained in the Methods section.
All the retrieved and computed information obtained
by the data processing step is stored in the QueryOR
database.
The overall time required for loading and process-
ing data is approximately proportional to the number
of variants. Typically, for ~100,000 unique variants
(6-8 exomes) the time required is less than 20 min. A
more detailed analysis of the loading time is given in
Additional file 1: Figure S1.
Interactive queries and results analysis
After the completion of data processing, the user can ex-
plore the information that has been associated to the
project, following the general procedure shown in Fig. 2.
Queries can be formulated very easily and the resulting
answers are typically delivered in a few seconds that can
extend to minutes for very complex queries. Thus it is
possible to experiment different criteria and parameters,
to perform a comprehensive investigation and to get
progressively closer to possible causative genes. A de-
tailed analysis of the querying time, as a function of
the number of criteria and variants can be found in
Additional file 1: Figure S2.
The complete route from query to variant takes five
progressive steps that correspond to pages appearing on
the web browser, labelled Q1 to Q5. At each step some
decisions must be taken: Q1 is for the query, Q2 is for
choosing a gene from the resulting list, Q3 is for the se-
lection of a specific transcript among the different iso-
forms, Q4 corresponds to the transcript report where a
certain variant can be chosen and Q5 is the description
of the variant. Like being in a maze, you may explore
some paths and you can go back if the route leads to a
dead end. In the web browser, Q1 to Q5 will open as in-
dependent pages making it easy to return to any of the
previous steps. Some integrated QueryOR tools are asso-
ciated to different points of this route, to make decisions
easier. The main features of this process are described in
the following paragraphs.
Query procedure (Q1)
Page Q1 allows the user to select the criteria for
prioritization that are grouped into seven main sections.
Three sections (ENSEMBL Features, Functional Annota-
tion and Phenotype Annotation) are related to genes, path-
ways and phenotypes. In these sections it is possible to
select for specific lists of genes and transcripts as well as
features like gene ontology, gene expression and associa-
tions to pathways, diseases or phenotypes. The remaining
four sections are related to variants. These include Variants
Annotation (for instance genomic context and functional
prediction scores), Variants Databases (for instance
dbSNP, EVS and COSMIC), Variants Sharing and Seg-
regation (variants in homozygosity and/or heterozy-
gosity present or absent in different individuals) and
VCF User Data (for instance variant coverage, geno-
type and quality calls).
Each section can be exploded to visualize sub-
sections that can be further expanded to see the select-
able criteria. Figure 2-Q1 shows a query page where
the section Variants Databases shows four sub-sections
and where the last sub-section (dbSNP) shows six se-
lectable criteria. The selected criteria are shown on the
right side of frame Q1 where GMAF is under defin-
ition, while other 7 defined criteria are shown in their
“collapsed” view.
By default all criteria have the same relevance in the
ranking process, but this can be modified by assigning
different weights to each criterion. There are no restric-
tions in the number of selected criteria, but very com-
plex queries may take a longer processing time.
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Engine (Q2)
When a query is submitted, the system performs an in-
dependent search for each of the selected criteria; then,
the score of each variant is calculated as the sum of the
weights of the satisfied criteria. Finally, genes are ranked
according to their highest-score variant. The results
from the query are summarized in a score table (right
part of Fig. 2-Q2) that shows the number of genes and
variants associated to each score. The two top-scores
shown in the right side of Fig. 2-Q2 were selected and
expanded to produce the results matrix on the left,
where each row reports a single gene combined with the
number of variants satisfying the prioritization criteria.
By clicking on a gene name in the results matrix, more
details show up. For instance, the image in Fig. 2-Q2
was taken after expanding FUCA2 and BPIFB3. This fea-
ture is useful to better understand the results. In fact, al-
though the first six genes have positive variants in every
column, as shown by the blue background, only 2 genes
satisfy all the 8 selected criteria, resulting in an associated
score of 8. This apparent incongruence can be explained
by looking at the expanded data of BPIFB3, showing that
although the gene has some variants satisfying all the cri-
teria, the two best variants satisfy only 7 criteria.
From the bottom line of Q2 (Total Number of Vari-
ants) it is possible to appreciate the depth and the strin-
gency of each filter and to make a general evaluation of
the prioritization. Thus the user can reconsider some of
the criteria and go back to Q1 to redefine the query.
Gene overview (Q3)
This page is shown after a gene is selected by clicking
on the Gene-ID, in the results matrix. The page displays
a compact graphical representation of alternative tran-
scripts associated to the selected gene, together with the
position and type of each variant across all samples. In
Fig. 2-Q3, two samples named APM and APN are shown
at the top of the frame. Both samples share a heterozy-
gous variant, represented by the white dots. The bottom
part of the Q3 frame shows two alternative transcripts in
which the same variant acts as a missense mutation
(dark blue dot) in one transcript and as an intronic
mutation (gray dot) in the other.
In the case of trio studies, samples are differently
tracked to highlight parental heritage of allelic variants
(haplotype configuration), as shown in Fig. 3.
Transcript report (Q4)
Detailed information about the transcript selected in Q3
is shown in Q4 (Figs. 2 and 3), where various contents
are briefly described and directly linked to their primary
source on the web. The variants that emerged from the
prioritization process are highlighted with a blue back-
ground. If the BAM file is available on the client side,
Fig. 3 Trio analysis. In the Q3 section, the arrow points to a variant that is heterozygous in both parents and homozygous in the child (full green bar).
At the end of the next exon, the child displays a heterozygous variant, shown as a small green bar, which was directly inherited from the father. A
detailed description of the variants is given in the Q4 section where the user can also find a link to the IGV viewer, that will be conveniently opened
on the appropriate genomic position
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the user can consider to launch IGV [43] that will auto-
matically point to the position of the variant under ana-
lysis to view the alignment of the reads on the genome.
By the “Varinfo” button the user can move to Q5.
Variant overview (Q5)
This page allows the evaluation of the specific features of
the candidate variant (Fig. 2-Q5) where several pathogen-
icity scores are accessible, including the above mentioned
PolyPhen and SIFT, as well as Mutation Taster [44],
CADD [45] and DANN [46]. Although these features are
sometimes discordant, it is useful to have a global view
to estimate the possible pathogenicity of the variant
under analysis.
Advanced analyses
From page Q2 it is possible to access other QueryOR’s
tools such as the “Variants Report” that is a printable
table summarizing the information on variants, genes
and pathogenicity. Another link builds a “Chromosome
map” reporting possible Runs Of Homozygosity, that
can be important in the analysis of human disorders, as
they represent a good clue for the presence of deleteri-
ous variants responsible for recessive diseases [47]. A
further link takes the user to the “Gene Analysis tool”
that allows the identification of genes carrying different
mutations among a group of patients. With this tool it is
possible to investigate unrelated patients or to investi-
gate diseases caused by de novo mutations, where it is
more important to know if the same gene is mutated in
different patients rather than if they share the same vari-
ant. This information comes as a summary table flanked
by a distribution chart (data not shown). Each group of
genes can be further investigated searching for shared
biological terms, using DAVID [48], or for common
pathways within Reactome [32] and KEGG [31].
Case study
To evaluate the performance of the platform we re-
analyzed some of the data published by de Ligt et al.
[38], (EGA study EGAS00001000287), concerning pa-
tients affected by recessive forms of cognitive impair-
ment and mental retardation. Our prioritization strategy
was achieved by applying several criteria on trio number
4 (VCF files EGAZ00001004509, EGAZ00001004510,
EGAZ00001004511). In particular: 1) we selected high
confidence variants with coverage level >60 and 2) with
alternative allele coverage >30; 3) we only considered
variants that changed the amino acid sequence; 4) as the
disease is rare, we imposed a low frequency threshold with
maf < 0.05; 5) the results were further fine-tuned by con-
sidering the “intellectual disability” Phenotype Ontology
keyword; 6) taking into consideration the pattern of inher-
itance, we selected variants that are homozygous only in
the child. QueryOR identified only two variants that could
satisfy these six criteria. Interestingly, one of the two is a
missense variant placed in the PDHA1 gene, in the X
chromosome, corresponding to that proposed in the
aforementioned work [38]. It is interesting to point out
that with only six criteria it was possible to achieve a very
effective prioritization. The above case is fully explained in
a tutorial available at http://queryor.cribi.unipd.it/cgi-bin/
queryor/tutorial.pl. To prevent any incidental findings and
to preserve patients privacy, the tutorial is based on the
exome of a healthy patient, manually edited to insert the
above variant.
Discussion
It is normal that when a new technology starts to pro-
duce novel types of data, the development of software
analysis runs a little behind and eventually catches up.
In the case of Whole Genome and Exome Sequencing
this problem is particularly relevant because the scope of
the prioritization process is not limited to the variants as
such, but it extends also to a wide variety of data and in-
formation that is continuously updated and is often
superseded by new discoveries.
When we started the development of QueryOR, this
context of generalized “work in progress” was one of our
main concerns. Prioritization is essentially a process of
data integration and to develop it using unstable datasets
would be a vain effort. On the other hand, we thought that
a user friendly variant-prioritization platform, suitable for
a wide range of analyses, could be of great utility. To over-
come the problem of sustainability, QueryOR has been
designed on a general schema rather than on predefined
databases. A dedicated XML language permits the declar-
ation of the datasets to be implemented in the platform.
Each dataset is defined for its content, for the possible
queries and for their web representation (layout, form
elements, hyperlinks, highlighted columns), thus making
the system flexible and scalable.
Thanks to this flexibility many datasets are available in
the platform while more will be added in the future. Al-
though a query could be potentially made by selecting
different features from all the available datasets, in a
normal session only some of the data will be interro-
gated. Thus there is a double level in which the informa-
tion is organized: at the basal level there are all the
available datasets implemented by the QueryOR man-
ager, while at the top there is the information emerging
from the queries performed by the end-users.
In literature, several bioinformatic tools for whole exome
analysis are reported, but only a few of them are suitable
for a comprehensive and efficient exome investigation. In
fact, while some platforms center their analyses on gene
features found in biological ontologies, others focus pri-
marily on variant annotations, disregarding gene function.
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In QueryOR we combined the most useful features found
in other tools, gathering and expanding them within a sin-
gle platform. Moreover, to enhance the potential of the
analyses, we implemented some important features such as
the annotation of minor alleles in the reference genome,
several prioritization criteria based on VCF information
such as coverage, genotype and quality score, as well as cri-
teria based on sharing variants and homozygosity in differ-
ent individuals. Furthermore, we introduced the possibility
to implement customized prioritization criteria based
on databases supplied by the user. A detailed descrip-
tion of the procedure for submitting custom tables is
given in the User Manual, available in the “Info” sec-
tion of the web site. Figure 4 compares the main fea-
tures of QueryOR with other available tools, including
SeattleSeq [49], wANNOVAR [6], VEP [50], BierApp
[19], PhenIX [10] and OVA [51].
To our knowledge, QueryOR is the open web tool with
the widest spectrum of applicable criteria (currently 70)
for exome data prioritization, spanning from gene and
variant annotations, to intrinsic features of the VCF file.
Another interesting peculiarity of QueryOR regards the
opportunity to select a subset of samples within a multi-
sample project, allowing focusing on attributes found
only in the chosen group of samples.
A major effort has been made to simplify the formula-
tion of complex queries. To perform a query the user
can select any combination of criteria and associated pa-
rameters. For instance, one of the criteria could be the
minimal coverage of the locus where a SNP occurs and
the associated parameter could be “30”. Criteria can be
classified in three main categories. The first group is
based on the knowledge of genes and diseases, exploiting
Fig. 4 Comparison of QueryOR with other platforms for variant
prioritization. The platforms were tested using a VCF input file. The
indicated number of available criteria is approximate due to different
ways of implementation
Fig. 5 Usage of the criteria for “shared” and “homozygous” variants
in a trio case. Diamonds indicate different hypotheses that can be
made. For instance, if we hypothesize a recessive homozygous variant
in the child we should set two criteria: 1) shared variants by child and
both parents and 2) homozygous variants only in the child. Whereas, for
a compound heterozygosity we would expect that the child shares the
variants, but we do not know which variant is in which parent;
furthermore, the variant should not be homozygous in the parents.
Compound heterozygosities are generally difficult to find and criteria
based only on sharing and homozygosity would not be selective
enough. In this case the “Gene Analysis tool” described in the text could
help in the selection of genes carrying different mutations. Sometimes it
may be useful to set criteria that may appear useless, like homozygosity
on a X chromosome; however this may help to reduce false positives
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the functional and phenotypical annotation integrated in
QueryOR as well as lists of candidate disease genes
when available. The second category discriminates vari-
ants on the basis of information contained in the VCF
file including coverage, genotype and quality of calling.
The third category is related to variant features, such as
pathogenicity scores, effect on protein, population fre-
quency and distribution among the project samples. In
particular, it is possible to impose a specific inheritance
model in trios as schematized in Fig. 5, or families
and cohorts, allowing for instance the selection of
variants shared or not shared among different patients
or that are homozygous in some patients and hetero-
zygous in others.
In the development of the graphical user interface, we
dedicated a particular attention to user friendliness, both
for setting the criteria and for interpreting the results.
As an example, Fig. 6 shows how de novo mutations can
be searched and visualized in a trio of mother, father
and child.
In contrast with other similar tools that return only
the items that simultaneously satisfy all the query speci-
fications, QueryOR sorts the results on the number and
weight of satisfied criteria; thus, the user can have a glo-
bal view of which criteria are or are not met for every
gene and can decide whether to continue the investiga-
tion or modify the query. The integration of a wide
range of heterogeneous information and the automated
annotation procedure provides the end user with the
ability to evaluate the information at various levels in
order to establish the relationships between different
data and to discriminate between causal and neutral
variants.
Several other innovative features of QueryOR make
the process of prioritization thorough and at the same
time easy. For instance, an important issue is that we an-
notated all the variants that in the reference genome are
represented by rare alleles, that we named mAiRs
(minor Allele in Reference). These variants can either
be filtered off by the query specification or alternatively
they will be automatically labelled as mAiR when seen
on the selected genes.
Conclusion
Currently, QueryOR is primarily used to analyse exomes
and gene panels, however it has been successfully
employed also for whole genomes. In this respect the
main problem is the lack of functional information that
can be associated to variants belonging to non-coding
sequences. As this information will become available we
will take advantage of the flexibility of QueryOR to im-
plement datasets that may facilitate the prioritization of
variants in whole genome analyses.
In conclusion, the comprehensiveness of the imple-
mented criteria and the aptness to add new features to-
gether with a user-friendly environment make QueryOR
very suitable to support researchers, clinicians and ge-
neticists engaged in variant analyses.
Availability and requirements
Project name: QueryOR
Platform home page: http://queryor.cribi.unipd.it
Tutorial: http://queryor.cribi.unipd.it/cgi-bin/queryor/
tutorial.pl
User manual: http://queryor.cribi.unipd.it/cgi-bin/
queryor/user_manual.pl
Access requirements: Web browser
Access restrictions: None
Additional file
Additional file 1: This file contains supplementary figures supporting
the manuscript. Figure S1 time required for uploading and processing a
project. Figure S2 time required for the processing of a query. (ODT 121 kb)
Fig. 6 Searching for de novo mutations in a trio. Q1: to set the criteria the user should select “Shared variants” and click the box beside each
patient, selecting green, red or gray respectively for present, absent and ignore, while the sentence underneath will report in plain English the
meaning of the settings; more criteria can be set by clicking the + symbol. Q3: the results include haplotype phasing. The yellow bar indicated by
the arrow is a possible de novo mutation. For the meaning of other symbols see Fig. 3
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